Skyepharma has extensive know-how and experience in the application of inhalation formulation, device and process technologies covering both Dry Powder Inhaler (DPI) and Metered Dose Inhaler (MDI) products.
Each drug, target product profile and device presents specific challenges in order to meet formulation, clinical, regulatory, manufacturing and patient-use requirements. We apply our many years of experience in the development of different products and devices to maximise the probability of project success. Where appropriate we apply our own proprietary formulation and device technologies to solve particular problems and to add additional patent protection to the product.
> Find out more about our inhalation formulation technologies
> Find out more about our inhalation device technologies